Acquisition expected to immediately increase transaction volume, revenue
and overall gross margins
MONTREAL, Jan. 11 /CNW/ - Aptilon Corporation ("Aptilon" or the
"Corporation") (TSX-V: APZ), a leading provider of physician access through
its innovative alternative sales and marketing channel, today announced that
it has reached an agreement to acquire all the issued and outstanding shares
of Tinderbox Partners Inc. ("Tinderbox"), a digital marketing firm for
pharmaceutical marketers. Tinderbox operates Allied Health Partners ("AHP"),
an online network of medical and other partner channels offering innovative
and unprecedented access to healthcare professionals. Aptilon will pay total
consideration of $ 2,835,000 comprised of $ 1,535,000 payable in cash and
$ 1,300,000 payable by the issuance of 3,250,000 common shares of Aptilon at a
deemed price of $ 0.40 per share for the shares of Tinderbox. The transaction
is expected to close on about January 16, 2008.
"This acquisition of Tinderbox, which includes Allied Health Partners
network, significantly enhances the value that we bring to our growing base of
top pharmaceutical companies," said Denis Martineau, President of Aptilon.
"This transaction, in combination with the previously announced acquisition of
Mikich Company, the company operating Med2020.com and GasJobs.com, will
strengthen the leadership position of the Aptilon ReachNetSM Physician Access
Channel, by significantly increasing throughput and the number of paid
transactions, while generating an immediate positive impact on gross margins."
Established in 2003, and based in Montreal, Quebec, Tinderbox offers
services, information, and loyalty programs to a large base of U.S. and North
American healthcare professionals through its wholly-owned network and partner
network, Allied Health Partners. Using this network, Tinderbox helps
pharmaceutical marketers plan and implement online campaigns to effectively
reach these sought after healthcare professionals.
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device companies to
effectively reach and interact with physicians via the Internet through its
innovative AxcelRxSM Live video detailing (with company reps), virtual
programs, peer selling and other sales and marketing programs. Leading health
care companies have adopted Aptilon's ReachNetSM Physician Access Channel,
driving tens of thousands of high-quality rep-physician interactions averaging
from eight to ten minutes in length. Aptilon provides the infrastructure
necessary for sales representatives to build physician awareness,
understanding and preference during all stages of a product's life cycle, from
pre-launch education through end stage support. For more information, visit
AxcelRxSM and ReachNetSM are service marks of Aptilon Corporation.
This news release contains forward-looking information. These statements
relate to future events or future performance and reflect management's current
expectations and assumptions. Such forward-looking statements reflect
management's current beliefs and are based on information currently available
to management of Aptilon. A number of factors could cause actual events,
performance or results to differ materially from the events performance and
results discussed in the forward-looking statements. These forward-looking
statements are made as of the date hereof and Aptilon does not assume any
obligation to update or revise them to reflect new events or circumstances.
The TSX Venture Exchange Inc. has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Denis Martineau, President, Aptilon
Corporation, 1-888-544-8866, firstname.lastname@example.org; Arianna Vanin, Investor
Relations, The Equicom Group, (514) 844-4680, email@example.com; For
U.S. Media: Mark Gleason, Aptilon Corporation, (847) 331-8628,
firstname.lastname@example.org; For Canadian Media: Alexandra Malka, Aptilon
Corporation, 1-888-544-8866, email@example.com